RARRES1 and hepatocellular carcinoma: Next, we tested lenvatinib sensitivity in two HCC cell lines (Huh7 and SKHEP1), and found that only RARRES1 knockdown could decrease cell sensitivity to lenvatinib at concentrations of 31.25 and 62.5 μM; therefore, further analysis of RARRES1 was conducted.